Release Date: 17/08/09 09:51 Summary: Extension to voluntary suspension Price Sensitive: No Download Document 140.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%